Panic Attack Treatment Market Forecast (2026–2030) Providing Long-Term Insights

The Business Research Company’s 2026 market reports feature enhanced tools like market attractiveness analysis, TAM assessment, and company scoring matrices, along with interactive dashboards, deeper supply chain insights, and startup coverage strengthening the depth, usability, and strategic value of insights.

What Is The Estimated Market Size Of The Panic Attack Treatment Market In 2026, And How Will Its Value Evolve By 2030?

The panic attack treatment market size has shown substantial growth in recent years. It is projected to increase from $3.58 billion in 2025 to $4.21 billion in 2026, exhibiting a compound annual growth rate (CAGR) of 17.6%. The historical development in this market can be linked to aspects like insufficient awareness of panic attack treatments, a strong dependence on in-person therapy, the elevated cost of specialized medications, a fragmented mental healthcare infrastructure, and a low rate of adoption for digital therapy tools.

The panic attack treatment market is projected to experience rapid growth over the next few years. This market is expected to reach $7.97 billion by 2030, growing at a compound annual growth rate (CAGR) of 17.3%. The expansion during the forecast period can be attributed to the increasing adoption of telehealth platforms, growth in virtual reality and digital therapeutics, the rising prevalence of anxiety and panic disorders, advancements in personalized medicine, and the expansion of online pharmacy and hospital distribution channels. Key trends in the forecast period include the rising adoption of telepsychiatry and mobile health applications, the integration of virtual reality therapy for panic disorders, increasing use of neurofeedback and biofeedback techniques, growth in personalized medication plans, and the expansion of mental healthcare centers and hospital services.

Access Your Free Sample Report For In-Depth Market Analysis:

https://www.thebusinessresearchcompany.com/sample.aspx?id=24356&type=smp

Which Key Factors Are Driving The Panic Attack Treatment Market Growth?

The escalating prevalence of anxiety is projected to stimulate expansion within the panic attack treatment market in the future. Anxiety is defined as a mental health condition marked by ongoing sensations of worry, apprehension, and fear, frequently accompanied by physical manifestations like agitation, a rapid heart rate, and trouble concentrating. The demands of contemporary living contribute to elevated anxiety levels by imposing ceaseless requirements for productivity, financial stability, and social achievement, leaving scant opportunity for recuperation or emotional recovery. Panic attack treatment aims to manage anxiety by providing effective interventions to ease symptoms, foster emotional well-being, and assist individuals in regaining command over their lives through customized and prompt approaches. For instance, in May 2024, as per the American Psychiatric Association (APA), a US-based medical specialty society representing psychiatrists nationwide, a rising proportion of U.S. adults are reporting increased anxiety, with 43% in 2024 indicating higher anxiety levels compared to 37% in 2023 and 32% in 2022. Hence, the increasing prevalence of anxiety is fueling the panic attack treatment market.

How Is The Panic Attack Treatment Market Organized By Segment Classification?

The panic attack treatment market covered in this report is segmented –

1) By Treatment Type: Cognitive Behavioral Therapy (CBT), Medications, Other Treatment Types

2) By Drug Class: Antidepressants, Anti-Anxiety Drugs, Calcitonin Gene-Related Peptide (CGRP) Antagonists, Other Drug Classes

3) By Route Of Administration: Oral, Sublingual, Other Routes Of Administration

4) By Distribution Channel: Hospital Pharmacies, Retail Pharmacies, Online Pharmacies

5) By Application: Hospitals, Mental Healthcare Centers, Other Applications

Subsegments:

1) By Cognitive Behavioral Therapy (CBT): Exposure Therapy, Dialectical Behavior Therapy (DBT), Acceptance And Commitment Therapy (ACT), Mindfulness-Based Cognitive Therapy (MBCT), Rational Emotive Behavior Therapy (REBT)

2) By Medications: Beta Blockers, Buspirone, Anticonvulsants, Atypical Antipsychotics, Herbal And Natural Supplements

3) By Other Treatment Types: Telepsychiatry, Biofeedback And Neurofeedback, Virtual Reality Therapy, Mobile Health Applications, Support Groups And Counseling Services

Which Trends Are Guiding The Direction Of The Panic Attack Treatment Market?

Major companies operating in the panic attack treatment market are increasingly focusing on breakthroughs in medical technology, including digital anxiety relief platforms, to enhance the management of anxiety and panic attacks through readily available, technology-enabled solutions. Digital anxiety relief platforms are technology-based applications or services created to assist individuals in handling and reducing anxiety using tools such as guided meditation, cognitive behavioral therapy modules, mood tracking, and various relaxation exercises. For instance, in October 2024, CalmiGo, a US-based mental health startup, unveiled CalmiGo Plus, an advanced digital platform engineered to support users in more effectively managing anxiety and panic attacks. This platform features a patented, sensor-based exhaler device and a corresponding mobile application that utilizes gamification and personalized therapeutic techniques to improve mental health outcomes. This innovation allows users to experience immediate, drug-free relief while also monitoring their progress over time, representing a significant advancement in accessible and data-driven anxiety treatment solutions.

Who Are The Industry Participants Involved In The Panic Attack Treatment Market?

Major companies operating in the panic attack treatment market are Pfizer Inc., Johnson & Johnson Services Inc., F. Hoffmann-La Roche Ltd., Sanofi S.A., AstraZeneca Plc, Novartis AG, GlaxoSmithKline plc, Takeda Pharmaceutical Company Limited, Eli Lilly and Company, Viatris Inc., Teva Pharmaceutical Industries Ltd., Sun Pharmaceutical Industries Ltd., Sumitomo Dainippon Pharma, Lundbeck A/S, Torrent Pharmaceuticals Ltd., Merck & Co Inc., Bristol-Myers Squibb Company, Otsuka Pharmaceutical Co Ltd, Boehringer Ingelheim International GmbH, Allergan plc, Alkermes plc, Jazz Pharmaceuticals plc, Bayer AG, Amgen Inc., Cipla Limited

Get The Full Panic Attack Treatment Market Report:

https://www.thebusinessresearchcompany.com/report/panic-attack-treatment-global-market-report

Which Region Has The Greatest Market Share In The Panic Attack Treatment Market?

North America was the largest region in the panic attack treatment market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the panic attack treatment market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Request A Customized Panic Attack Treatment Market Report For Competitive Insights:

https://www.thebusinessresearchcompany.com/report/panic-attack-treatment-global-market-report

Browse Through More Reports Similar to the Global Panic Attack Treatment Market 2026, By The Business Research Company

Pancreatic Cancer Drugs Market Report 2026

https://www.thebusinessresearchcompany.com/report/pancreatic-cancer-drugs-global-market-report

Digestive Enzyme Market Report

https://www.thebusinessresearchcompany.com/report/digestive-enzyme-global-market-report

Pancreatic Cancer Diagnostic Market Report

https://www.thebusinessresearchcompany.com/report/pancreatic-cancer-diagnostic-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795